Pharmafile Logo

vaccine reimbursement

- PMLiVE

Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence

Inizio

Two_Women_Running_Making_Health_Whole

The silent drop-off: How disengagement shows up in everyday behaviour

In healthcare, disengagement rarely announces itself. It doesn’t always appear as refusal or a clear decision to stop treatment. More often, it shows up quietly, in what is delayed, avoided...

Mednet

- PMLiVE

adelo acquires Dot I/O Health, with Nigel Breakwell becoming Managing Partner

Nigel Breakwell was formerly Joint CEO of Edelman London and MD of WCG

- PMLiVE

Innovative Trials appoints Anita Owen as first COO

Owen was most recently Senior Vice President for Clinical Operations at Caidya

- PMLiVE

Keep the Beat Going: Education and Impact at the European Society of Cardiology Heart Failure Congress 2026

Did you know? Over 320,000 learners have engaged with heart failure content on Medscape. With such an enthusiastic audience for our education, we’re thrilled to be joining cardiology professionals from...

Medscape Education

- PMLiVE

The Power of Partnership in Respiratory Care

In the fast-paced world of modern medicine, success is often measured by the volume of tests and the precision of data. However, as Dr. Doreen Addrizzo-Harris and Dr. Martina Flammer...

Medscape Education

- PMLiVE

UCB presentation highlights impacts of epilepsy on daily life

The data underlines the consequences of disrupted sleep for patients and caregivers

- PMLiVE

Inventiva appoints Axel-Sven Malkomes as Chief Financial Officer

Malkomes was most recently CFO at CureVac

Person_Swimming

Why clinical innovation doesn’t translate into real-life outcomes

We’ve made extraordinary progress in healthcare. However, outcomes depend on whether people can make treatment work in their lives.

Mednet

- PMLiVE

Strategies to enhance the provider and patient EAP experience

Expanded access programs (EAPs) play a multifaceted role in the drug development life cycle, serving as a critical bridge between clinical trials and commercial availability.

Uniphar

- PMLiVE

Biogen agrees $850m felzartamab rights deal with TJ Biopharma

The agreement gives Biogen full global rights to the investigational antibody across immune-mediated diseases

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links